Recently, Hunan Hengtaikang Rehabilitation Medical Industry Development Co., Ltd. (hereinafter referred to as "Hengtaikang Company") has taken a series of measures to deal with the relevant situation of its subsidiary Xiangyang Hengtaikang Hospital. Aier Medical Investment Group urges Hunan Hengtaikang Rehabilitation Medical Industry Development Co., Ltd., as the controlling management of Xiangyang Hengtaikang Hospital, to respond quickly and take the following measures:

Immediately establish a special working group and dispatch the core management team to Xiangyang on February 5th to fully cooperate with the government's investigation work;

Deploy the remaining 16 hospitals under its umbrella to comprehensively carry out self-examination and self correction, strictly compare medical insurance policies and medical standards for investigation, and initiate a special compliance rectification for the entire hospital;

We reiterate our zero tolerance stance towards any violation of laws, regulations, and medical ethics, and clarify that after the investigation is completed, relevant responsible persons will be dealt with seriously in accordance with the law and regulations, and will not be tolerated.